Humana, UnitedHealthcare Hit Hard as Star Ratings Decline for Third Year

  • Oct 17, 2024

    CMS on Oct. 10 released the 2025 Medicare Advantage and Part D Star Ratings, revealing a continued decline in the number of plans achieving high ratings. Only 40% of Medicare Advantage Prescription Drug (MA-PD) contracts earned 4 stars or higher for the 2025 plan year, though 62% of all MA-PD members are enrolled in these highly rated contracts, which will qualify for bonus payments in 2026. This marks the third consecutive year of declining ratings, reflecting the continued return to normal after pandemic-era flexibilities and the impact of the second year of the Tukey outlier deletion methodology, which in some cases “caused an upward shift in cut points,” CMS explained. Just seven contracts received a 5-star rating, a steep decline from 38 in 2024. An additional seven contracts — five from Centene Corp., one from CVS Health Corp.’s Aetna and one from Zing Health — received the "low-performing" indicator. Read more
    © 2024 MMIT
  • Carina Belles

    Carina has been covering public-sector health care since 2018. As a data reporter for Radar on Medicare Advantage, she creates infographics and data stories on issues impacting Medicare, Medicaid and Part D. She also develops AIS Health Daily, a free daily newsletter that showcases AIS’s strong reporting across our four publications and parent company Norstella’s suite of market access and data solutions. Prior to joining the editorial team, she managed Medicare and Medicaid data for the Directory of Health Plans, AIS’s industry-standard health coverage database. She graduated from Ohio University with a B.S. in Journalism.

The Latest
Meet Our Reporters

Meet Our Reporters

×
×